FK 463

Known as: FK-463, FK463 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2006
Highly Cited
2006
BACKGROUND Micafungin (FK463) is a new lipopeptide compound (echinocandin) with activity against Aspergillus and Candida species… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Micafungin (FK463) is a new parenteral echinocandin. A multicenter, phase I, open-label, sequential-group dose escalation study… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2004
Highly Cited
2004
The efficacy and safety of micafungin (FK463), which is a new lipopeptide antifungal agent of the echinocandin class and is… (More)
Is this relevant?
Highly Cited
2002
Highly Cited
2002
We evaluated the in vitro activity of the new echinocandin antifungal micafungin against Candida spp. using microdilution and… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Micafungin (FK463) is an echinocandin that demonstrates potent in vitro antifungal activities against Candida and Aspergillus… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Review
2002
Review
2002
FK-463 (micafungin) represents the latest development candidate in a novel chemical class of echinocandin lipopeptide antifungal… (More)
Is this relevant?
2001
2001
We investigated the potential synergy between two cell wall-active agents, the echinocandin FK463 (FK) and the chitin synthase… (More)
Is this relevant?
2000
2000
The efficacy of intravenous injection of FK463, a novel water-soluble lipopeptide, was evaluated in mouse models of disseminated… (More)
Is this relevant?
2000
2000
The antifungal activities of FK463 against various pathogenic fungi were tested by standard broth microdilution methods, and… (More)
  • figure 1
  • table I
  • table 2
  • table 3
  • table 4
Is this relevant?
Review
2000
Review
2000
Development of new approaches for treatment of invasive fungal infections encompasses new delivery systems for approved and… (More)
Is this relevant?